Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ACUTAAS CHEMICALS LTD.

NSE : ACUTAASBSE : 543349ISIN CODE : INE00FF01025Industry : Pharmaceuticals & DrugsHouse : Private

BSE2544.3519.05 (+0.75 %)

PREV CLOSE ( ) 2525.30

OPEN PRICE ( ) 2534.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 26456

TODAY'S LOW / HIGH ( )2474.50 2561.85

52 WK LOW / HIGH ( )930.02 2580

NSE2545.0017.7 (+0.7 %)

PREV CLOSE( ) 2527.30

OPEN PRICE ( ) 2515.20

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 750071

TODAY'S LOW / HIGH( ) 2473.40 2561.40

52 WK LOW / HIGH ( )976.55 2580

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-06 2007

Management Info

Nareshkumar Patel - Chairman Nareshkumar Patel - Managing Director

Registered Office

Address Plot No 440/5 & 6,Road No 82,G I D C Sachin,
Surat,
Gujarat-394230

Phone 7227977744 / 7573015366

Email info@acutaas.com

Website www.acutaas.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

02Mar Acutaas Chemicals informs about analys
Acutaas Chemicals has informed that the Company’s Officials will physica..

12Feb Acutaas Chemicals’ arm buys 75% stake
Acutaas Chemicals’ wholly owned subsidiary -- Acutaas Advance Material (..

29Jan Acutaas Chemicals informs about press
Acutaas Chemicals has informed that it enclosed newspaper publication of..

19Jan Acutaas Chemicals informs about updat
Pursuant to Regulation 30 and other applicable regulations of SEBI (List..

22Dec Intimation Of Grant Of Stock Options
We herewith inform that the Nomination and Remuneration Committee has to..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	1115.64	1595.47
Gross Profit	1507.03	2135.76
Operating Profit	1605.35	2434.78
Net Sales	3908.56	9898.35

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Onesource Specialty (BSE) 1452.15 (6.99%)	M.Cap ( in Cr)16644.72
Emcure Pharma (BSE) 1653.60 (3.75%)	M.Cap ( in Cr)31350.53
Anthem Biosciences (BSE) 681.20 (5.44%)	M.Cap ( in Cr)38263.95
Mankind Pharma (BSE) 2040.25 (0.99%)	M.Cap ( in Cr)84227.30
Gland Pharma (BSE) 1728.75 (1.16%)	M.Cap ( in Cr)28482.27

Shareholding Pattern

	PROMOTERS	32.66%
	NON-INSTITUTION	28.96%
	MUTUAL FUNDS/UTI	15.11%
	FI/BANKS/INSURANCE	4.15%
	GOVERNMENT	0.01%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
SBI Healthcare Opp ...	2.97
Union Innovation & ...	2.78
Kotak Consumption F...	2.67
Bank of India ELSS ...	2.54
Union Small Cap Fun...	2.40
Samco Special Oppor...	2.29
Kotak Healthcare Fu...	2.27

Risk Disclosures on Derivatives

Smart Quotes

ACUTAAS CHEMICALS LTD.